Checked.be
Active
BE 0825.151.779Public limited company
BIOXODES
Rue Santos - Dumont 1 ·6041 Charleroi, Belgium· 16 yrs active
Sector: NACE 72101
(72101)
Conclusion
The computed 12-month bankruptcy probability of BIOXODES is 0.3% (very low). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Key figures
| Active | 16 yrs |
| Board | 3 |
| Locations | 1 |
| Publications | 31 |
Bankruptcy probability (12 mo)
0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Lower-risk legal form
−Long track record
−
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
Established
Founded in 2010, 16 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No administrative flags
Financial overview
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 16-07-2025 | 2025-00274086 |
| 31-12-2023 | volledig | 23-07-2024 | 2024-00271025 |
| 31-12-2022 | volledig | 14-07-2023 | 2023-00235430 |
| 31-12-2021 | volledig | 23-08-2022 | 2022-20305384 |
| 31-12-2020 | volledig | 13-07-2021 | 2021-34200330 |
| 31-12-2019 | volledig | 04-08-2020 | 2020-37700413 |
| 31-12-2018 | volledig | 25-06-2019 | 2019-21500537 |
| 31-12-2017 | volledig | 31-07-2018 | 2018-40100346 |
| 31-12-2016 | volledig | 08-08-2017 | 2017-41400415 |
| 31-12-2015 | volledig | 30-06-2016 | 2016-24900476 |
Directors & mandates
Current directors & mandates
-
Current02-10-2025 → present
-
Current05-10-2022 → present
2 events
- 08-11-2022 Appointed· Director
- 05-10-2022 Mandate renewed· Daily management
-
SAS CROUGHS R&D CONSULTINGLegal entityDirector· perm. rep.: Thérèse CroughsState Gazette act 21036646 (23-03-2021)Current15-12-2020 → present
Historic, not recently confirmed (10)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
-
JCO ConsultingLegal entityDirector· perm. rep.: Jean CombalbertState Gazette act 19107912 (08-08-2019)Not recently confirmedlast confirmed in an act from 2019
-
AJE ConsultingLegal entityDirector· perm. rep.: GODFROID EdmondState Gazette act 15132919 (18-09-2015)Not recently confirmedlast confirmed in an act from 2015
-
CAPITAL & CROISSANCELegal entityDirector· perm. rep.: DETRIXHE PierreState Gazette act 15132919 (18-09-2015)Not recently confirmedlast confirmed in an act from 2015
2 events
- 18-09-2015 Mandate renewed· Director
- 10-07-2013 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2015
-
Not recently confirmedlast confirmed in an act from 2015
2 events
- 18-09-2015 Mandate renewed· Director
- 01-01-2014 Appointed· Director
-
JCO ConsultingLegal entityDirector· perm. rep.: COMBALBERT JeanState Gazette act 15132919 (18-09-2015)Not recently confirmedlast confirmed in an act from 2015
2 events
- 18-09-2015 Mandate renewed· Director
- 10-12-2013 Appointed· Director
-
Life Sciences Research PartnersLegal entityDirector· perm. rep.: BUYSE ChrisState Gazette act 15132919 (18-09-2015)Not recently confirmedlast confirmed in an act from 2015
-
SPRL AJE CONSULTINGLegal entityDirector· perm. rep.: Edmond GodfroidState Gazette act 14105977 (23-05-2014)Not recently confirmedlast confirmed in an act from 2014
2 events
- 10-12-2013 Appointed· Director
- 10-12-2013 Appointed· Managing director
-
Not recently confirmedlast confirmed in an act from 2013
-
Not recently confirmedlast confirmed in an act from 2013
Former directors (8)
-
AJE CONSULTING SRLLegal entityDaily management· perm. rep.: Edmond GODFROIDState Gazette act 22130605 (04-11-2022)Former05-10-2022 → 16-12-2024
3 events
- 16-12-2024 Resigned· Director
- 16-12-2024 Resigned· Managing director
- 05-10-2022 Mandate renewed· Daily management
-
Former10-07-2013 → 01-01-2019
2 events
- 01-01-2019 Resigned· Director
- 10-07-2013 Appointed· Director
-
SPRL TCF ConsultingLegal entityDirector· perm. rep.: Oliver BoucherState Gazette act 15090815 (26-06-2015)Former- → 10-06-2015
-
SPRL TCF ConsuitingLegal entityDaily management· perm. rep.: Oliver BoucherState Gazette act 15048473 (02-04-2015)Former- → 21-01-2015
-
SPRL CARKATHLegal entityDirector· perm. rep.: Eric HaliouaState Gazette act 14143093 (24-07-2014)Former- → 01-01-2014
-
Former04-07-2013 → 10-12-2013
7 events
- 10-12-2013 Resigned· Director
- 10-12-2013 Resigned· Managing director
- 10-07-2013 Mandate renewed· Director
- 10-07-2013 Appointed· Managing director
- 04-07-2013 Appointed· Managing director
- 04-07-2013 Appointed· Director
- 04-07-2013 Resigned· Director
-
Former04-07-2013 → 10-07-2013
2 events
- 10-07-2013 Resigned· Director
- 04-07-2013 Appointed· Director
-
Former04-07-2013 → 10-07-2013
2 events
- 10-07-2013 Resigned· Director
- 04-07-2013 Appointed· Director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| PwC Réviseurs d'Entreprises SRLCurrent Statutory auditor · represented by Didier DELANOYE |
- | 27-02-2025 → present |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
| NACE primary | 72101 |
| Legal form | Public limited company(014) |
| Incorporation | 20-04-2010 |
| Status | Active |
| Postal code | 6041 |
Connections & network
Group structure
Parent · 1 subsidiary · 1 location
Control→
Parent · 9 subsidiaries · 1 location
Control→
Parent · 3 subsidiaries · 1 location
Control→
Parent · 2 subsidiaries · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Network connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Establishment units
BIOXODES
since 20102.187.055.535
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2026
07-08-2026
State Gazette act
General meeting · Director reappointment
2025
16-07-2025
NBB filing
Annual accounts filed
2024
23-07-2024
NBB filing
Annual accounts filed
2023
14-07-2023
NBB filing
Annual accounts filed
2022
23-08-2022
NBB filing
Annual accounts filed
2021
13-07-2021
NBB filing
Annual accounts filed
2020
04-08-2020
NBB filing
Annual accounts filed
2019
25-06-2019
NBB filing
Annual accounts filed
2018
31-07-2018
NBB filing
Annual accounts filed
2017
08-08-2017
NBB filing
Annual accounts filed
2016
30-06-2016
NBB filing
Annual accounts filed
Belgisch Staatsblad, acts
Capital history · 17
01-07-2025
v3.2
02-07-2024
v3.2
11-01-2024
v3.2
31-10-2023
v3.2
03-01-2023
v3.2
17-12-2021
v3.2
20-07-2021
v3.2
24-04-2019
v3.2
03-04-2019
v3.2
28-12-2015
v3.2
02-12-2015
v3.2
23-09-2015
v3.2
02-09-2015
v3.2
24-06-2015
v3.2
18-07-2014
v3.2
Address history · 1
04-11-2022
v3.2
All acts · 31
updated 3 days ago
2026
07-08-2026 General meeting · Officer reappointment · Permanent representative · Board meeting
- Publication: 07/08/2026 · BIOXODES
- Filing: 29/07/2026 · BIOXODES
- General meeting: 30/06/2026 · BIOXODES
- Officer reappointment: role: administrateur, term: 6 ans, start_date: 2026-07-01 · SRL XMF
- Officer reappointment: role: administrateur, term: 6 ans, start_date: 2026-07-01 · SRL PHMBIO+
- Officer reappointment: role: administrateur, term: 6 ans, start_date: 2026-07-01 · SC CAPITAL & CROISSANCE
- Officer reappointment: role: administrateur, term: 6 ans, start_date: 2026-07-01 · SA S.F.P.I. (Société Fédérale de Participations et d'Investissements)
- Officer reappointment: role: administrateur, term: 6 ans, start_date: 2026-07-01 · SAS CROUGHS R&D CONSULTING
- Permanent representative · Marc DECHAMPS
- Permanent representative · Philippe MONTEYNE
- Permanent representative · Pierre DETRIXHE
- Permanent representative · François FONTAINE
- Permanent representative · Thérèse CROUGHS
- Board meeting: 03/07/2026 · BIOXODES
- Officer appointment: role: gestion journalière, term: durée de son mandat d'administrateur, start_date: 2026-07-01 · SRL XMF
- Officer appointment: role: présidence du conseil d'administration, term: durée de son mandat d'administrateur, start_date: 2026-07-01 · SRL PHMBIO+
- Auditor appointment: role: commissaire, term: 4 ans, start_date: 06/02/2025 · SRL PwC Réviseurs d'Enreprises
- Permanent representative · Didier DELANOYE
- Filing representative: mandataire spéciale · Francine MESSINNE
Summary:
General meeting · Officer reappointment · Permanent representative · Board meeting
Technical details
{
"facts": [
{
"date": "2026-08-07",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 07/08/2026",
"value": "07/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-29",
"type": "filing",
"quote": "29 JUIL. 2026",
"value": "29/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-30",
"type": "general_meeting",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire du 30 juin 2026",
"value": "30/06/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "officer_reappointment",
"quote": "a d\u00E9cid\u00E9 de renouveler le mandat des administrateurs sortants suivants... la SRL XMF... pour une dur\u00E9e de six ans, prenant effet le 1er juillet 2026",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "01/07/2026"
}
},
{
"date": "2026-07-01",
"type": "officer_reappointment",
"quote": "a d\u00E9cid\u00E9 de renouveler le mandat des administrateurs sortants suivants... la SRL PHMBIO\u002B... pour une dur\u00E9e de six ans, prenant effet le 1er juillet 2026",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "01/07/2026"
}
},
{
"date": "2026-07-01",
"type": "officer_reappointment",
"quote": "a d\u00E9cid\u00E9 de renouveler le mandat des administrateurs sortants suivants... la SC CAPITAL \u0026 CROISSANCE... pour une dur\u00E9e de six ans, prenant effet le 1er juillet 2026",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "01/07/2026"
}
},
{
"date": "2026-07-01",
"type": "officer_reappointment",
"quote": "a d\u00E9cid\u00E9 de renouveler le mandat des administrateurs sortants suivants... la SA S.F.P.I.... pour une dur\u00E9e de six ans, prenant effet le 1er juillet 2026",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "01/07/2026"
}
},
{
"date": "2026-07-01",
"type": "officer_reappointment",
"quote": "a d\u00E9cid\u00E9 de renouveler le mandat des administrateurs sortants suivants... la SAS CROUGHS R\u0026D CONSULTING... pour une dur\u00E9e de six ans, prenant effet le 1er juillet 2026",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e10",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "01/07/2026"
}
},
{
"type": "permanent_representative",
"quote": "la SRL XMF, ayant pour repr\u00E9sentant permanent M. Marc DECHAMPS",
"value": null,
"object": "e2",
"subject": "e3"
},
{
"type": "permanent_representative",
"quote": "la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE",
"value": null,
"object": "e4",
"subject": "e5"
},
{
"type": "permanent_representative",
"quote": "la SC CAPITAL \u0026 CROISSANCE, ayant pour repr\u00E9sentant permanent M. Pierre DETRIXHE",
"value": null,
"object": "e6",
"subject": "e7"
},
{
"type": "permanent_representative",
"quote": "la SA S.F.P.I.... ayant pour repr\u00E9sentant permanent M. Fran\u00E7ois FONTAINE",
"value": null,
"object": "e8",
"subject": "e9"
},
{
"type": "permanent_representative",
"quote": "la SAS CROUGHS R\u0026D CONSULTING, ayant pour repr\u00E9sentante permanente Mme Th\u00E9r\u00E8se CROUGHS",
"value": null,
"object": "e10",
"subject": "e11"
},
{
"date": "2026-07-03",
"type": "board_meeting",
"quote": "Le conseil d\u0027administration, r\u00E9uni par \u00E9crit le 3 juillet 2026",
"value": "03/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-01",
"type": "officer_appointment",
"quote": "confi\u00E9 la gestion journali\u00E8re de la Soci\u00E9t\u00E9 \u00E0 la SRL XMF... avec effet au 1er juillet 2026 et pour la dur\u00E9e de son mandat d\u0027administrateur",
"value": {
"role": "gestion journali\u00E8re",
"term": "dur\u00E9e de son mandat d\u0027administrateur",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "gestion journali\u00E8re",
"term": "dur\u00E9e de son mandat d\u0027administrateur",
"start_date": "01/07/2026"
}
},
{
"date": "2026-07-01",
"type": "officer_appointment",
"quote": "confi\u00E9 la pr\u00E9sidence du conseil d\u0027administration \u00E0 la SRL PHMBIO\u002B... avec effet au 1er juillet 2026 et pour la dur\u00E9e de son mandat d\u0027administrateur",
"value": {
"role": "pr\u00E9sidence du conseil d\u0027administration",
"term": "dur\u00E9e de son mandat d\u0027administrateur",
"start_date": "2026-07-01"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "pr\u00E9sidence du conseil d\u0027administration",
"term": "dur\u00E9e de son mandat d\u0027administrateur",
"start_date": "01/07/2026"
}
},
{
"date": "2025-02-06",
"type": "auditor_appointment",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire du 6 f\u00E9vrier 2025 a d\u00E9sign\u00E9 la SRL PwC R\u00E9viseurs d\u0027Enreprises, en qualit\u00E9 de commissaire de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre ans",
"value": {
"role": "commissaire",
"term": "4 ans",
"start_date": "06/02/2025"
},
"object": "e1",
"subject": "e12"
},
{
"type": "permanent_representative",
"quote": "Le prepr\u00E9sentant permanant est M. DIdier DELANOYE",
"value": null,
"object": "e12",
"subject": "e13"
},
{
"type": "filing_representative",
"quote": "Francine MESSINNE avocate mandataire sp\u00E9ciale",
"value": "mandataire sp\u00E9ciale",
"object": "e1",
"subject": "e14"
}
],
"act_meta": {
"outcome": "clean",
"postfix": [
"kbo \u0027811 926 955 00014\u0027 invalid -\u003E null (raw kept)"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 3189,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0825.151.779",
"kind": "company",
"name": "BIOXODES",
"attrs": {
"seat": "rue Santos Dumont 1 \u00E0 6041 Gosselies",
"legal_form": "soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": "0659.744.114",
"kind": "company",
"name": "SRL XMF",
"attrs": {
"seat": "Avenue Louis David 68, 1410 Waterloo",
"legal_form": "SRL"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Marc DECHAMPS",
"attrs": {}
},
{
"id": "e4",
"kbo": "0631.922.633",
"kind": "company",
"name": "SRL PHMBIO\u002B",
"attrs": {
"seat": "All\u00E9e Bois du Bercuit 101, 1390 Grez-Doiceau",
"legal_form": "SRL"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Philippe MONTEYNE",
"attrs": {}
},
{
"id": "e6",
"kbo": "0890.073.384",
"kind": "company",
"name": "SC CAPITAL \u0026 CROISSANCE",
"attrs": {
"seat": "Parc d\u0027activit\u00E9s \u00E9conomiques du WEX, rue de la Plaine 11, 6900 Marche-en-Famenne",
"legal_form": "SC"
}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Pierre DETRIXHE",
"attrs": {}
},
{
"id": "e8",
"kbo": "0253.445.063",
"kind": "company",
"name": "SA S.F.P.I. (Soci\u00E9t\u00E9 F\u00E9d\u00E9rale de Participations et d\u0027Investissements)",
"attrs": {
"seat": "Avenue Louise 32 bo\u00EEte 4, 1050 Bruxelles",
"legal_form": "SA"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Fran\u00E7ois FONTAINE",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "company",
"name": "SAS CROUGHS R\u0026D CONSULTING",
"attrs": {
"seat": "5 rue Etienne Dolet, 92130 Issy-les-Moulineaux (France)",
"kbo_raw": "811 926 955 00014",
"legal_form": "SAS"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Th\u00E9r\u00E8se CROUGHS",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "company",
"name": "SRL PwC R\u00E9viseurs d\u0027Enreprises",
"attrs": {
"legal_form": "SRL"
}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Didier DELANOYE",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Francine MESSINNE",
"attrs": {
"address": "avocate"
}
}
]
}2025
16-10-2025 Philippe MONTEYNE appointed as director
- Philippe MONTEYNE, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0631922633",
"name": "SRL PHMBIO\u002B",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-10-02",
"evidence_quote": "act\u00E9 la d\u00E9signation comme administrateur: la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE, immatricul\u00E9e \u00E0 la BCE sous le n\u00BA BE0631.922.633 et ayant son si\u00E8ge All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau, pour une dur\u00E9e d\u0027un an avec effet imm\u00E9diat et jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9ral"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}01-07-2025 Capital decrease of €9,069,205.78 to €395,844.41
- €9.465.050,19 → €395.844,41
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 8398992.55,
"currency": "EUR",
"after_eur": 9465050.19,
"delta_eur": 8398992.55,
"before_eur": 1066057.64,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2025-06-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une augmentation de capital, sans cr\u00E9ation de titres, par incorporation des primes d\u2019\u00E9mission constitu\u00E9es lors de pr\u00E9c\u00E9dentes augmentations de capital, d\u0027un montant total de 8.398.992,55 \u20AC pour porter le capital temporairement de 1.066.057,64 \u20AC \u00E0 9.465. 050,19 \u20AC.",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 9069205.78,
"currency": "EUR",
"after_eur": 395844.41,
"delta_eur": -9069205.78,
"before_eur": 9465050.19,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-06-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de 9.069.205,78 \u20AC, sans annulation de titres, pour le ramener de 9.465. 050,19 \u20AC \u00E0 395.844,41 \u20AC, par apurement \u00E0 due concurrence de la perte report\u00E9e figurant \u00E0 la situation comptable arr\u00EAt\u00E9e au 31 d\u00E9cembre 2024.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}27-02-2025 1 director appointed, 2 resigning
- Didier DELANOYE, Commissaris
- Edmond GODFROID, Bestuurder
- Edmond GODFROID, Gedelegeerd bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-16",
"evidence_quote": "act\u00E9 la d\u00E9mission de AJE CONSULTING SRL, ayant pour repr\u00E9sentant permament M. Edmond GODFROID, de ses fonctions d\u0027administrateur et de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, avec effet au 16 d\u00E9cembre 2024"
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-16",
"evidence_quote": "act\u00E9 la d\u00E9mission de AJE CONSULTING SRL, ayant pour repr\u00E9sentant permament M. Edmond GODFROID, de ses fonctions d\u0027administrateur et de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, avec effet au 16 d\u00E9cembre 2024"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "d\u00E9sign\u00E9 la SRL PwC R\u00E9viseurs d\u0027Entreprises, en qualit\u00E9 de commissaire de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre ans, jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale charg\u00E9e d\u0027approuver les comptes annuels arr\u00EAt\u00E9s au 31 d\u00E9cembre 2017. Le repr\u00E9sentant permanent est M. Didier DELANOYE"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2024
02-07-2024 Transaction in capital or shares
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}11-01-2024 Capital increase of €2,456.50 to €1,066,057.64
- €1.063.601,14 → €1.066.057,64
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 2456.5,
"currency": "EUR",
"after_eur": 1066057.64,
"delta_eur": 2456.5,
"before_eur": 1063601.14,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-01-08",
"evidence_quote": "L\u0027administrateur pr\u00E9cit\u00E9 constate l\u0027augmentation de capital de 2.456,50 \u20AC pour le porter de 1.063.601,14 \u20AC \u00E0 1.066.057,64 \u20AC par la cr\u00E9ation de 24.565 actions ordinaires nouvelles... Les actions nouvelles ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2023
31-10-2023 Capital increase of €372,938.70 to €1,063,601.14
- €690.662,44 → €1.063.601,14
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 372938.7,
"currency": "EUR",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-10-26",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de 372.938,70 \u20AC, pour le porter de 690.662,44 \u00E0 1.063.601,14 \u20AC",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 1200000,
"currency": "EUR",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2023-10-26",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide de renouveler l\u2019autorisation... d\u2019augmenter le capital \u00E0 concurrence d\u2019un maximum de 1.200.000 \u20AC",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}03-01-2023 Capital increase of €8,561,218.28 to €9,251,880.72
- €690.662,44 → €9.251.880,72
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 8561218.28,
"currency": "EUR",
"after_eur": 9251880.72,
"delta_eur": 8561218.28,
"before_eur": 690662.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-29",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide donc d\u0027augmenter temporairement le capital \u00E0 concurrence de 8.561.218,28 \u20AC pour le porter de 690.662,44 \u20AC \u00E0 9.251.880,72 \u20AC.",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 8561218.28,
"currency": "EUR",
"after_eur": 690662.44,
"delta_eur": -8561218.28,
"before_eur": 9251880.72,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-29",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de 8.561.218,28 \u20AC, sans annulation de titres, pour le ramener de 9.251.880,72 \u20AC \u00E0 690.662,44 \u20AC",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2022
22-12-2022 Marc DECHAMPS appointed as director
- Marc DECHAMPS, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc DECHAMPS",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0659744114",
"name": "SRL XMF",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-11-08",
"evidence_quote": "La SRL XMF, d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re (immatricul\u00E9e \u00E0 la BCE sous le n\u00B00659.744.114 et dont le si\u00E8ge est situ\u00E9 Avenue Louis David 68 \u00E0 1410 Waterioo, Belgique), ayant pour repr\u00E9sentant permanent Monsieur Marc DECHAMPS, est nomm\u00E9e administrateur de Bioxodes"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}04-11-2022 Registered office moved from Marche-en-Famenne to Gosselies
- rue de la Plaine 11, 6900 Marche-en-Famenne → Santos Dumont 1, 6041 Gosselies
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gosselies",
"region": "Waals",
"street": "Santos Dumont",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "1"
},
"old_address": {
"city": "Marche-en-Famenne",
"region": "Waals",
"street": "rue de la Plaine",
"country": "BE",
"postcode": "6900",
"box_number": null,
"street_number": "11"
},
"effective_date": "2022-10-14",
"evidence_quote": "Le si\u00E8ge social est transf\u00E9r\u00E9 rue Santos Dumont 1 \u00E0 6041 Gosselies avec effet imm\u00E9diat."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2021
17-12-2021 Capital increase of €121,437 to €690,662.44
- €569.225,44 → €690.662,44
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 121437.0,
"currency": "EUR",
"after_eur": 690662.44,
"delta_eur": 121437.0,
"before_eur": 569225.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2021-12-15",
"evidence_quote": "L\u2019administrateur pr\u00E9cit\u00E9 constate l\u0027augmentation de capital \u00E0 concurrence de 121.437,00 \u20AC pour le porter de 569.225,44 \u20AC \u00E0 690.662,44 \u20AC par la cr\u00E9ation de 1.214.370 actions privil\u00E9gi\u00E9es nouvelles... Les actions nouvelles ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}20-07-2021 Capital increase of €189,741.80 to €758,967.24
- €569.225,44 → €758.967,24
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 189741.8,
"currency": "EUR",
"after_eur": 758967.24,
"delta_eur": 189741.8,
"before_eur": 569225.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2021-07-08",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale approuve ces rapports \u00E0 l\u0027unanimit\u00E9 Ensuite de quoi, l\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de 189.741,80 \u20AC, pour le porter de 569.225,44 \u20AC \u00E0 758.967,24 \u20AC, par la cr\u00E9ation de 1.897.418 actions nouvelles, sans mention de valeur nominale, du m\u00EAme type et jouissant des m\u00EAmes droits et avantages que les actions privil\u00E9gi\u00E9es existantes.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}23-03-2021 Thérèse Croughs appointed as director
- Thérèse Croughs, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Th\u00E9r\u00E8se Croughs",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SAS CROUGHS R\u0026D CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-12-15",
"evidence_quote": "La SAS CROUGHS R\u0026D CONSULTING, repr\u00E9sent\u00E9e par Madame Th\u00E9r\u00E8se Croughs, est nomm\u00E9e administrateur ind\u00E9pendant de la SA Bioxodes, avec effet au 15 d\u00E9cembre 2020."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2020
17-07-2020 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2019
08-08-2019 1 director appointed, 1 resigning
- Jean Combalbert, Bestuurder
- Jean COMBALBERT, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean COMBALBERT",
"address": null,
"birth_date": null
},
"effective_date": "2019-01-01",
"evidence_quote": "la Soci\u00E9t\u00E9 a pris acte de la d\u00E9mission de M. Jean COMBALBERT, comme administrateur, avec effet au 1er janvier 2019"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean Combalbert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0693684414",
"name": "SPRL JCO Consulting",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-01-01",
"evidence_quote": "la nomination comme administrateur, de la SPRL JCO Consulting, dont le si\u00E8ge social est situ\u00E9 Cit\u00E9 du sureau 7 B1 \u00E0 1000 Bruxelles, immatricul\u00E9e \u00E0 la BCE sous le n\u00B0 693.684.414 et ayant pour repr\u00E9sentant permanent M. Jean Combalbert, avec effet au 1er janvier 2019"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}24-04-2019 Capital increase of €157,320.63 to €569,225.44
- €411.904,81 → €569.225,44
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 157320.63,
"currency": "EUR",
"after_eur": 569225.44,
"delta_eur": 157320.63,
"before_eur": 411904.81,
"amount_type": "kapitaal_effectief",
"effective_date": "2019-04-09",
"evidence_quote": "Les administrateurs pr\u00E9cit\u00E9s constatent l\u0027augmentation de capital de cent cinquante-sept mille trois cent vingt euros soixante trois cents (157.320,63 \u20AC) pour le porter de quatre cent onze mille neuf cent quatre euros quatre-vingt et un cents (411.904,81 \u20AC) \u00E0 cing cent soixante-neuf mille deux cent vingt-cinq euros quarante quatre cents (569.225,44 \u20AC) par la cr\u00E9ation de un million cing cent septante-trois mille deux cent quatre (1.573.204) actions privil\u00E9gi\u00E9es nouvelles... Les actions nouvelles ont \u00E9t\u00E9 souscrites en esp\u00E8ce... Les actions nouvelles ont \u00E9t\u00E9 totalement lib\u00E9r\u00E9es \u00E0 la souscription et la prime d\u0027\u00E9mission lib\u00E9r\u00E9e int\u00E9gralement, par le versement au compte num\u00E9ro BE75 0018 5876 7651 ouvert au nom de la soci\u00E9t\u00E9 aupr\u00E8s de la banque Fortis Banque. A l\u0027appui de cette d\u00E9claration, les administrateurs remettent au notaire soussign\u00E9 l\u0027attestation bancaire d\u00E9livr\u00E9e en date du 9 avril 2019.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}03-04-2019 Capital increase of €157,293.30 to €564,767.61
- €407.474,31 → €564.767,61
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 76399.5,
"currency": "EUR",
"after_eur": 407474.31,
"delta_eur": 76399.5,
"before_eur": 331074.81,
"amount_type": "kapitaal_effectief",
"effective_date": "2019-03-20",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide donc d\u0027\u00E9changer: - les cent (100) obligations convertibles \u00E9mises le 3 d\u00E9cembre 2015 contre trois cent quatorze mille cing cent quatre-vingt-six (314.586) actions privil\u00E9gi\u00E9es nouvelles... - les cent (100) obligations convertibles \u00E9m\u00EDses le 20 avril 2018 contre quatre cent quarante-neuf mille quatre cent neuf (449.409) actions privil\u00E9gi\u00E9es nouvelles... En cons\u00E9quence de quoi, l\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de septante-six mille trois cent nonante-neuf euros cinquante cents (76.399,50 \u20AC) pour le porter de trois cent trente et un mille septante-quatre euros quatre-vingt un cents (331.074,81 \u20AC) \u00E0 quatre cent sept mille quatre cent septante-quatre euros trente et un cents (407.474,31 \u20AC)",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 157293.3,
"currency": "EUR",
"after_eur": 564767.61,
"delta_eur": 157293.3,
"before_eur": 407474.31,
"amount_type": "kapitaal_effectief",
"effective_date": "2019-03-20",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027une seconde augmentation de capital \u00E0 concurrence d\u0027au minimum cent cinquante sept mille deux cent nonante-trois euros trente cents (157.293,30 \u20AC) pour le porter de quatre cent sept mille quatre cent septante-quatre euros trente et un cents (407.474,31 \u20AC) \u00E0 cinq cent soixante-quatre mille sept cent soixante-sept euros soixante et un cents (564.767,61 \u20AC) par la cr\u00E9ation de un million cinq cent septante-deux mille neuf cent trente-trois (1.572.933) actions privil\u00E9gi\u00E9es nouvelles... Les actions souscrites devront \u00EAtre totalement lib\u00E9r\u00E9es \u00E0 la souscription et la prime d\u0027\u00E9mission devra \u00EAtre lib\u00E9r\u00E9e int\u00E9gralement.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2015
28-12-2015 Capital increase of €76,877 to €331,074.81
- €254.197,81 → €331.074,81
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 76877,
"currency": "EUR",
"after_eur": 331074.81,
"delta_eur": 76877.0,
"before_eur": 254197.81,
"amount_type": "kapitaal_effectief",
"effective_date": "2015-12-14",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de septante-six mille huit cent septante-sept euros (76.877 \u20AC) pour le porter de deux cent cinquante-quatre mille cent nonante-sept euros quatre-vingt un cents (254.197,81 \u20AC) \u00E0 trois cent trente et un mille septante-quatre euros quatre-vingt un cents (331.074,81 \u20AC)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}02-12-2015 Capital increase of €76,877 to €331,074.81
- €254.197,81 → €331.074,81
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 76877,
"currency": "EUR",
"after_eur": 331074.81,
"delta_eur": 76877.0,
"before_eur": 254197.81,
"amount_type": "kapitaal_effectief",
"effective_date": "2015-12-14",
"evidence_quote": "Augmentation du capital \u00E0 concurrence de 76.877 EUR pour le porter de 254.197,81 EUR \u00E0 331.074,81 EUR",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}23-09-2015 Capital increase of €60,170.71 to €254,197.81
- €194.027,10 → €254.197,81
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 60170.71,
"currency": "EUR",
"after_eur": 254197.81,
"delta_eur": 60170.71,
"before_eur": 194027.1,
"amount_type": "kapitaal_effectief",
"effective_date": "2015-09-08",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de soixante mille cent septante euros septante et un cents (60.170,71 \u20AC) pour le porter de cent nonante-quatre mille vingt-sept euros dix cents (194.027,10 \u20AC) \u00E0 deux cent cinquante-quatre mille cent nonante-sept euros quatre-vingt un cents (254.197,81 \u20AC)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}18-09-2015 1 director appointed, 5 reappointed
- DE RADIGUES DE CHENNEVIERE Hervé, Bestuurder
- GODFROID Edmond, Bestuurder
- BUYSE Chris, Bestuurder
- COMBALBERT Jean, Bestuurder
- DETRIXHE Pierre, Bestuurder
- HALIOUA Eric, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GODFROID Edmond",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0536527190",
"name": "AJE CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de renouveler le mandat d\u0027administrateur de: - la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e \u0022AJE CONSULTING\u0022 \u00E0 Bruxelles (1120) rue Hoogeleest, 23, inscrite au registre des personnes morales sous le num\u00E9ro 0536527190, laquelle d\u00E9signe comme repr\u00E9sentant permanent Monsieur GODFROID E"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BUYSE Chris",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0435768243",
"name": "LIFE SCIENCES RESEARCH PARTNERS",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "- l\u0027association sans but lucratif \u0022LIFE SCIENCES RESEARCH PARTNERS\u0022 \u00E0 Leuven (3000) Herestraat, 49 bo\u00EEte 913, inscrite au registre des personnes morales sous le num\u00E9ro 0435.768.243, laquelle d\u00E9signe comme repr\u00E9sentant permanent Monsieur BUYSE Chris, domicili\u00E9 \u00E0 Herzele (9551) Borkebekestraat, 55;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "COMBALBERT Jean",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "JCO CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "- la soci\u00E9t\u00E9 \u0022JCO CONSULTING\u0022 \u00E0 Marseille (13008 - France) rue du Paradis, 506, num\u00E9ro de Siret 512 542 9111 00015, laquelle d\u00E9signe comme repr\u00E9sentant permanent Monsieur COMBALBERT Jean, domicili\u00E9 \u00E0 Saint-Gilles (1060 Bruxelles) rue Henri Wafelaerts, 2;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DETRIXHE Pierre",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0890073384",
"name": "CAPITAL \u0026 CROISSANCE",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "- la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e \u0022CAPITAL \u0026 CROISSANCE\u0022 \u00E0 Marche-en-Famenne (6900) Parc d\u0027activit\u00E9s \u00E9conomiques du WEX, rue de la Plaine 11, inscrite au registre des personnes morales sous le num\u00E9ro 0890.073.384, laquelle d\u00E9signe comme repr\u00E9sentant permanent Monsieur DETRIXHE Pierre"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HALIOUA Eric",
"address": null,
"birth_date": null
},
"evidence_quote": "- Monsieur HALIOUA Eric, domicili\u00E9 \u00E0 Uccle (1180 Bruxelles) rue Copernic, 6A \u0417."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DE RADIGUES DE CHENNEVIERE Herv\u00E9",
"address": null,
"birth_date": null
},
"evidence_quote": "d) L\u0027assembl\u00E9e nomme en outre, en qualit\u00E9 d\u0027administrateur: Monsieur le Baron DE RADIGUES DE CHENNEVIERE Herv\u00E9, domicili\u00E9 \u00E0 Verviers (4800) Chemin du Couloury, 11."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}02-09-2015 Capital increase of €60,170.71 to €254,197.81
- €194.027,10 → €254.197,81
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 60170.71,
"currency": "EUR",
"after_eur": 254197.81,
"delta_eur": 60170.71,
"before_eur": 194027.1,
"amount_type": "kapitaal_effectief",
"effective_date": "2015-09-08",
"evidence_quote": "Augmentation du capital \u00E0 concurrence de 60.170,71 EUR pour le porter de 194.027,10 EUR \u00E0 254.197,81 EUR",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}26-06-2015 Oliver Boucher resigns as director
- Oliver Boucher, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Oliver Boucher",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SPRL TCF Consulting",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-06-10",
"evidence_quote": "Par une d\u00E9cision du 10 juin 2015, l\u0027assembl\u00E9e g\u00E9n\u00E9rale a r\u00E9voqu\u00E9, avec effet imm\u00E9diat, le mandat de la SPRL TCF Consulting, ayant pour repr\u00E9sentant permanent M. Oliver Boucher."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}24-06-2015 Capital increase of €99,524.20 to €244,233.80
- €144.709,60 → €244.233,80
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 99524.2,
"currency": "EUR",
"after_eur": 244233.8,
"delta_eur": 99524.2,
"before_eur": 144709.6,
"amount_type": "kapitaal_effectief",
"effective_date": "2015-06-30",
"evidence_quote": "Augmentation du capitai \u00E0 concurrence de 99.524,20 EUR pour le porter de 144.709,60 EUR \u00E0 244.233,80 EUR",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}02-04-2015 Oliver Boucher resigns as daily management
- Oliver Boucher, Dagelijks bestuur
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Oliver Boucher",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SPRL TCF Consuiting",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-01-21",
"evidence_quote": "de mettre fin aux fonctions de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re de la SPRL TCF Consuiting (repr\u00E9sent\u00E9e par M. Oliver Boucher), avec effet imm\u00E9diat."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2014
24-07-2014 1 director appointed, 1 resigning
- Eric HALIOUA, Bestuurder
- Eric Halioua, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Eric Halioua",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SPRL CARKATH",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2014-01-01",
"evidence_quote": "Par une d\u00E9cision du 6 juin 2014, l\u0027assembl\u00E9e g\u00E9n\u00E9rale a act\u00E9 la d\u00E9mission de la SPRL CARKATH (repr\u00E9sentant permanent: Eric Halioua), de son mandat d\u0027administrateur avec effet au 1er janvier 2014"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Eric HALIOUA",
"address": null,
"birth_date": null
},
"effective_date": "2014-01-01",
"evidence_quote": "Par une d\u00E9cision du 6 juin 2014, l\u0027assembl\u00E9e g\u00E9n\u00E9rale a act\u00E9 la d\u00E9mission de la SPRL CARKATH (repr\u00E9sentant permanent: Eric Halioua), de son mandat d\u0027administrateur avec effet au 1er janvier 2014 et a nomm\u00E9 Monsieur Eric HALIOUA, administrateur, avec effet au 1er janvier 2014 et jusqu\u0027\u00E0 l\u0027assembl\u00E9e g"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}18-07-2014 Capital increase of €23,797.80 to €144,709.60
- €120.911,80 → €144.709,60
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 237980,
"currency": "EUR",
"after_eur": 144709.6,
"delta_eur": 23797.8,
"before_eur": 120911.8,
"amount_type": "kapitaal_effectief",
"effective_date": "2014-07-01",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de vingt-trois mille sept cent nonante-sept euros quatre-vingts cents (23.797,80 \u20AC) pour le porter de cent vingt mille neuf cent onze euros quatre-vingts cents (120.911,80 \u20AC) \u00E0 cent quarante-quatre mille sept cent neuf euros soixante cents (144.709,60 \u20AC) par la cr\u00E9ation de deux cent trente-sept mille neuf cent quatre-vingt (237.980) nouvelles actions dites privil\u00E9gi\u00E9es",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}26-06-2014 Capital increase of €237,980
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 237980,
"currency": "EUR",
"after_eur": null,
"delta_eur": 237980,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2014-07-01",
"evidence_quote": "Augmentation de capital d\u0027un montant de 23.797,80 \u20AC aveo paiement d\u0027une prime d\u0027\u00E9mission ... Emission de 237.980 nouvelles actions privil\u00E9gi\u00E9es",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}23-05-2014 3 directors appointed, 2 resigning
- Edmond Godfroid, Bestuurder
- Edmond Godfroid, Gedelegeerd bestuurder
- Jean COMBALBERT, Bestuurder
- Edmond GODFROID, Bestuurder
- Edmond GODFROID, Gedelegeerd bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"effective_date": "2013-12-10",
"evidence_quote": "Par une d\u00E9cision du 10 d\u00E9cembre 2013, l\u0027assembl\u00E9e g\u00E9n\u00E9rale a act\u00E9 la d\u00E9mission de Monsieur Edmond: GODFROID de son mandat d\u0027administrateur avec effet imm\u00E9diat"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Edmond Godfroid",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SPRL AJE CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2013-12-10",
"evidence_quote": "a nomm\u00E9 la SPRL AJE CONSULTING, administrateur, avec effet imm\u00E9diat et jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2019. Le repr\u00E9sentant permanent de la SPRL AJE CONSULTING est Monsieur Edmond Godfroid."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"effective_date": "2013-12-10",
"evidence_quote": "Par une d\u00E9cision du 18 mars 2014, le conseil d\u0027administration a act\u00E9 la d\u00E9mission de Monsieur Edmond GODFROID de son mandat d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 avec effet au 10 d\u00E9cembre 2013"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Edmond Godfroid",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SPRL AJE CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2013-12-10",
"evidence_quote": "et l\u0027a remplac\u00E9 par la SPRL AJE CONSULTING, ayant pour repr\u00E9sentant permanent Monsieur Edmond Godfroid."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean COMBALBERT",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "JCO CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2013-12-10",
"evidence_quote": "L\u0027assembl\u00E9e acte l\u0027exercice de son mandat d\u0027administrateur par Monsieur Jean COMBALBERT par le biais de la soci\u00E9t\u00E9 JCO CONSULTING, qui porte le num\u00E9ro Siret 512 542 9111 00015 et dont le si\u00E8ge social est situ\u00E9 rue du Paradis 506 \u00E0 13008 Marseille."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2013
10-07-2013 Capital increase of €59,411.80 to €120,911.80
- €61.500 → €120.911,80
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 59411.8,
"currency": "EUR",
"after_eur": 120911.8,
"delta_eur": 59411.8,
"before_eur": 61500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2013-06-27",
"evidence_quote": "Augmenter le capital \u00E0 concurrence de cinquante-neuf mille quatre cent onze euros quatre-vingts cents (59.411,80 \u20AC) pour le porter de soixante et un mille cing cents euros (61.500 \u20AC) \u00E0 cent vingt mille neuf cent onze euros quatre-vingts cents (120.911,80 \u20AC).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}First 30 of 31 acts
Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE)
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameFR | BIOXODES |
Registered office
Rue Santos - Dumont 1
6041 Charleroi, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
Aboleris Holdco
BE 0803.217.012 · Charleroi
CANCER STATE THERAPEUTICS
BE 0793.113.273 · Charleroi
CellCarta Biosciences
BE 0661.567.021 · Charleroi
Exo-Harvest
BE 0803.425.264 · Charleroi
Genflow Biosciences
BE 0753.904.685 · Charleroi